Oncoheroes is a ground-breaking biotech company exclusively focused on the discovery and development of better drugs for children and adolescents with cancer. The company is headquartered in Boston, US, with a discovery lab in Barcelona, Spain. Oncoheroes is working to generate new proprietary assets for a number of pediatric cancer indications with a high unmet medical need.
One of Oncoheroes’ strengths is the professional trajectory and commitment of the founders, two of them fathers of children who suffered cancer, and the rest of the team, with most members having more than 20 years of experience in drug development. In addition to that, we are proud of our Scientific Advisory Board, formed by world leaders in pediatric oncology, as well as the relationships already established with the main institutions and organizations of childhood cancer worldwide (e.g. ITCC (Europe), Children Oncology Group (US)).
Oncoheroes is working to generate new proprietary assets for a number of pediatric cancer indications with a high unmet medical need.
Due to insufficient specific therapies for children with cancer, pediatric oncologists are forced to adjust adult cancer treatments for childhood cancer. Only 4 treatments designed specifically for pediatric cancer have been approved by the FDA vs. more than 200 for adults. Oncoheroes is 100% focused on childhood cancer with a highly specialized team, network, and resources to bring new drugs developed for children.
Childhood cancer community
Foundation for Addie’s Research Joins Oncoheroes To Create More and Better Options for Children Fighting Cancer
Oncoheroes Biosciences
Vall d’Hebron Research Institute (VHIR) and Oncoheroes Biosciences to Partner for the Discovery and Development of Novel Therapies for Childhood Sarcomas
Oncoheroes Biosciences
Oncoheroes Biosciences and Allarity Therapeutics Sign Exclusive Pediatric Licensing Agreement for Dovitinib and Stenoparib
Oncoheroes Biosciences
Oncoheroes Biosciences Receives A Second Investment From Rally Foundation
Oncoheroes Biosciences
WEBINAR: Why Childhood Cancer Foundations Are Adopting The Venture Philantropy Approach
Oncoheroes Biosciences
Oncoheroes Biosciences receives a second investment from The Andrew McDonough B+ Foundation
Oncoheroes Biosciences
Oncoheroes Biosciences And Fundación Olivares: It Is Time For New And Better Therapies
Oncoheroes Biosciences
Oncoheroes Biosciences And The Scott Carter Foundation Are Onboard To End Childhood Cancer
Oncoheroes Biosciences
Oncoheroes Biosciences And Arms Wide Open Childhood Cancer Foundation Fighting Childhood Cancer Together
Oncoheroes Biosciences
Oncoheroes Biosciences And Swifty Foundation United Toward New Cures
Oncoheroes Biosciences
